Key Highlights

  • DRI Healthcare Trust (TSX:DHT.U) US dollar units fell 9.15% to USD 11.62 on Tuesday, October 20, 2026, on just 519 units, about 0.80 times normal volume.
  • The trust had not issued a release accounting for the move as of Wednesday, October 21, 2026, and a 519-unit print on the US dollar line is a thin basis for a price signal.
  • On Tuesday, August 11, 2026 the trust announced receipt of about USD 178 million for its EKTERLY royalty interest, a return of 1.5 times its purchase price.
  • Second-quarter total cash receipts were USD 46.5 million, and the trust paid its quarterly distribution of USD 0.11 per unit on Tuesday, October 20, 2026.

What Happened on the US Dollar Line

DRI Healthcare Trust (TSX:DHT.U) owns royalties on patent-protected pharmaceutical products and trades on the TSX in two lines: DHT.UN in CAD and DHT.U in US dollars. The US dollar units fell 9.15% to USD 11.62 on Tuesday, October 20, 2026, on 519 units, about 0.80 times their normal volume. The trust had not issued a release accounting for the move as of Wednesday, October 21, 2026. The main recent event is the EKTERLY put, an option to sell the royalty back at a set price, exercised after Chiesi Group acquired KalVista Pharmaceuticals and settled for about USD 178 million on Tuesday, August 11, 2026. Management put the return at 1.5 times cost and a high 20s internal rate of return.

Why a 519-Unit Trade Can Print a 9% Drop

DRI Healthcare Trust (TSX:DHT.U) concentrates most of its trading in the CAD line, so the US dollar line can go long periods between trades. At USD 11.62, the session volume was worth roughly USD 6,000 on own arithmetic. When a line trades that rarely, the percentage change compares one small trade with an earlier one that may be days old. A single seller crossing a wide bid and offer spread can therefore print a large decline. The October 20 payment of the USD 0.11 distribution does not explain the gap, because units traded without it from the September 30 record date. The economic value of a unit is the same across both lines after currency conversion, so the CAD line is the better guide.

Risks and What to Watch

The first risk for DRI Healthcare Trust (TSX:DHT.U) is reinvestment: the USD 178 million from EKTERLY earns little until it is redeployed, and pricing for pharmaceutical royalties is competitive. The second is leverage, with long-term debt of USD 372.3 million at June 30, 2026, including USD 247.4 million of senior notes, against cash of USD 55.2 million before the EKTERLY receipt. The third is product concentration, because income depends on the sales and patent life of a limited number of drugs. A trailing loss of USD 1.09 per unit reflects heavy non-cash amortisation. Investors should watch the third-quarter earnings call on Thursday, November 5, 2026, new royalty acquisitions and the next distribution declaration.

Where Things Stand

The answer is that DRI Healthcare Trust (TSX:DHT.U) fell 9.15% on a single thin print of 519 units, not on a disclosed event, so the move says more about liquidity than about the royalty portfolio. The EKTERLY put returned about USD 178 million in August, and redeployment is now the main question. The next catalysts are the November 5, 2026 earnings call, new royalty acquisitions and the distribution declaration. Distributions are not guaranteed, royalty income can fall and this is not investment advice.